News
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Bengaluru: Dr Thomas Chandy, former chairman, managing director, and chief of orthopaedics at HOSMAT Hospital, passed away ...
Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...
Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to ...
Scientists at Scripps Research and aTyr Pharma have characterized a protein that can soothe the inflammation associated with ...
A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...
A collection of immune cells known as a granuloma that results from chronic inflammation in the interstitial lung disease sarcoidosis. White dots indicate the receptor NRP2, which is overexpressed in ...
A new study finds that KL-6 and hSP-D levels can help predict progression of interstitial lung disease in patients with ...
Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.
A new study from Thailand shows that a rapid peak in skin thickness progression in systemic sclerosis patients may predict ...
Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...
New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results